Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance

Cancer is a result of a dynamic evolutionary process. It is composed of cancer cells and the tumour microenvironment (TME). One of the major cellular constituents of TME, cancer-associated fibroblasts (CAFs) are known to interact with cancer cells and promote colorectal carcinogenesis. The accumulat...

Full description

Bibliographic Details
Main Authors: Sahira Syamimi Ahmad Zawawi, Marahaini Musa
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biology
Subjects:
Online Access:https://www.mdpi.com/2079-7737/11/7/1014
_version_ 1827619152779542528
author Sahira Syamimi Ahmad Zawawi
Marahaini Musa
author_facet Sahira Syamimi Ahmad Zawawi
Marahaini Musa
author_sort Sahira Syamimi Ahmad Zawawi
collection DOAJ
description Cancer is a result of a dynamic evolutionary process. It is composed of cancer cells and the tumour microenvironment (TME). One of the major cellular constituents of TME, cancer-associated fibroblasts (CAFs) are known to interact with cancer cells and promote colorectal carcinogenesis. The accumulation of these activated fibroblasts is linked to poor diagnosis in colorectal cancer (CRC) patients and recurrence of the disease. However, the interplay between cancer cells and CAFs is yet to be described, especially in relation to the sidedness of colorectal carcinogenesis. CRC, which is the third most commonly diagnosed cancer globally, can be classified according to the anatomical region from which they originate: left-sided (LCRC) and right-sided CRC (RCR). Both cancers differ in many aspects, including in histology, evolution, and molecular signatures. Despite occurring at lower frequency, RCRC is often associated with worse diagnosis compared to LCRC. The differences in molecular profiles between RCRC and LCRC also influence the mode of treatment that can be used to specifically target these cancer entities. A better understanding of the cancer cell–CAF interplay and its association with RCRC and LRCR progression will provide better insight into potential translational aspects of targeted treatment for CRC.
first_indexed 2024-03-09T10:22:14Z
format Article
id doaj.art-6551538f7a604bf387b28952bccca14a
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-09T10:22:14Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-6551538f7a604bf387b28952bccca14a2023-12-01T21:54:27ZengMDPI AGBiology2079-77372022-07-01117101410.3390/biology11071014Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical RelevanceSahira Syamimi Ahmad Zawawi0Marahaini Musa1Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, MalaysiaHuman Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, MalaysiaCancer is a result of a dynamic evolutionary process. It is composed of cancer cells and the tumour microenvironment (TME). One of the major cellular constituents of TME, cancer-associated fibroblasts (CAFs) are known to interact with cancer cells and promote colorectal carcinogenesis. The accumulation of these activated fibroblasts is linked to poor diagnosis in colorectal cancer (CRC) patients and recurrence of the disease. However, the interplay between cancer cells and CAFs is yet to be described, especially in relation to the sidedness of colorectal carcinogenesis. CRC, which is the third most commonly diagnosed cancer globally, can be classified according to the anatomical region from which they originate: left-sided (LCRC) and right-sided CRC (RCR). Both cancers differ in many aspects, including in histology, evolution, and molecular signatures. Despite occurring at lower frequency, RCRC is often associated with worse diagnosis compared to LCRC. The differences in molecular profiles between RCRC and LCRC also influence the mode of treatment that can be used to specifically target these cancer entities. A better understanding of the cancer cell–CAF interplay and its association with RCRC and LRCR progression will provide better insight into potential translational aspects of targeted treatment for CRC.https://www.mdpi.com/2079-7737/11/7/1014colon canceractivated fibroblastevolutionheterogeneitysidedness
spellingShingle Sahira Syamimi Ahmad Zawawi
Marahaini Musa
Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance
Biology
colon cancer
activated fibroblast
evolution
heterogeneity
sidedness
title Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance
title_full Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance
title_fullStr Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance
title_full_unstemmed Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance
title_short Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance
title_sort dynamic co evolution of cancer cells and cancer associated fibroblasts role in right and left sided colon cancer progression and its clinical relevance
topic colon cancer
activated fibroblast
evolution
heterogeneity
sidedness
url https://www.mdpi.com/2079-7737/11/7/1014
work_keys_str_mv AT sahirasyamimiahmadzawawi dynamiccoevolutionofcancercellsandcancerassociatedfibroblastsroleinrightandleftsidedcoloncancerprogressionanditsclinicalrelevance
AT marahainimusa dynamiccoevolutionofcancercellsandcancerassociatedfibroblastsroleinrightandleftsidedcoloncancerprogressionanditsclinicalrelevance